Ebola outbreak: Japan offers experimental anti-flu drug to World Health Organisation for Ebola treatment

Favipiravir has not been tested on Ebola but scientists say it could work

Japan is offering an experimental anti-viral drug called favipiravir as a possible treatment for the Ebola virus.

The drug, known under the brand name Avignan, has been approved by Japan’s health ministry for use against flu but has not been tested on humans with Ebola.

The Chief Cabinet Secretary Yoshihide Suga said its manufacturers, a subsidiary of Fujifilm Holdings Corp, can ship the drug at any time on the request of the World Health Organisation (WHO).

Almost 1,500 people have so far been killed by the Ebola outbreak since March in Guinea, Liberia and Sierra Leone.

There is known cure or treatment for the disease, which has a fatality rate estimated at between 60 and 90 per cent.

 

Despite the recovery of the two American humanitarian workers treated with another experimental drug, ZMapp, a Spanish priest and Liberian doctor given the treatment have died.

Read more: First Briton to contract deadly virus now in London hospital isolation unit
William Pooley, the first Briton to contract Ebola since outbreak, described as a hero by colleagues
Disease claims first European victim as Spanish priest infected in Liberia dies
Ebola outbreak: What is ZMapp and could the experimental treatment stop the disease?

It was not possible to determine whether the American workers had recovered naturally like other Ebola survivors or whether it was due to the serum.

Spanish priest Miguel Pajares, who has died from Ebola, with a patient in Liberia Spanish priest Miguel Pajares, who has died from Ebola, with a patient in Liberia Only six people in the world are known to have received ZMapp and the small supply is now said to be exhausted.

Fujifilm is in talks with the US Food and Drug Administration over the clinical testing of favipiravir in treating Ebola, company spokesman Takao Aoki said.

He said Ebola and influenza viruses are the same general type and a similar response can theoretically be expected from both.

Favipiravir inhibits viral gene replication within infected cells to prevent propagation, while other anti-viral drugs often are designed to inhibit the release of new viral particles to prevent the spread of infection, the company said.

It has enough stock of favipiravir for more than 20,000 patients.

Mr Suga said Japan is waiting for a decision by WHO that would provide greater guidance on the use of untested drugs against Ebola.

In case of an emergency, Japan may respond to individual requests before any further decision by WHO, he said.

The UN agency said earlier this month that it is ethical to use untested drugs on Ebola patients given the magnitude of the outbreak.

Although several drugs are being developed for the treatment of the virus, they are still in the early stages.

The first Briton to contract the deadly virus arrived back in England from Sierra Leone on Sunday.

The patient, named as 29-year-old William Pooley, had been working with victims as a nurse and is being treated in a specialist isolation unit.

Additional reporting by AP

Read more: IRRATIONAL FEARS POTENTIALLY MORE DAMAGING THAN EBOLA
EBOLA HAULED THREE NATIONS OUT OF RECOVERY
NUMBER OF EBOLA DEATHS 'MASSIVELY UNDERESTIMATED'
Start your day with The Independent, sign up for daily news emails
Have you tried new the Independent Digital Edition apps?
News
ebooksAn unforgettable anthology of contemporary reportage
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Recruitment Genius: Business Development Manager / Sales - OTE £45,000

£35000 - £45000 per annum: Recruitment Genius: This company is a solutions / s...

Recruitment Genius: Sales Executive - OTE £45,000

£18000 - £45000 per annum: Recruitment Genius: A Sales Executive is required t...

Recruitment Genius: Test Development Engineer

£35000 - £40000 per annum: Recruitment Genius: Are you inspired to bring new a...

Recruitment Genius: Trainee Motor Engineer

£14000 - £18000 per annum: Recruitment Genius: This is an exciting opportunity...

Day In a Page

Sepp Blatter resignation: The beginning of Fifa's long road to reform?

Does Blatter's departure mean Fifa will automatically clean up its act?

Don't bet on it, says Tom Peck
Charles Kennedy: The baby of the House who grew into a Lib Dem giant

The baby of the House who grew into a Lib Dem giant

Charles Kennedy was consistently a man of the centre-left, dedicated to social justice, but was also a champion of liberty and an opponent of the nanny-state, says Baroness Williams
Syria civil war: The harrowing testament of a five-year-old victim of this endless conflict

The harrowing testament of a five-year-old victim of Syria's endless civil war

Sahar Qanbar lost her mother and brother as civilians and government soldiers fought side by side after being surrounded by brutal Islamist fighters. Robert Fisk visited her
The future of songwriting: How streaming is changing everything we know about making music

The future of songwriting

How streaming is changing everything we know about making music
William Shemin and Henry Johnson: Jewish and black soldiers receive World War I Medal of Honor amid claims of discrimination

Recognition at long last

Jewish and black soldiers who fought in WWI finally receive medals after claims of discrimination
Beating obesity: The new pacemaker which helps over-eaters

Beating obesity

The new pacemaker which helps over-eaters
9 best women's festival waterproofs

Ready for rain: 9 best women's festival waterproofs

These are the macs to keep your denim dry and your hair frizz-free(ish)
Cycling World Hour Record: Nervous Sir Bradley Wiggins ready for pain as he prepares to go distance

Wiggins worried

Nervous Sir Bradley ready for pain as he prepares to attempt cycling's World Hour Record
Liverpool close in on Milner signing

Liverpool close in on Milner signing

Reds baulk at Christian Benteke £32.5m release clause
On your feet! Spending at least two hours a day standing reduces the risk of heart attacks, cancer and diabetes, according to new research

On your feet!

Spending half the day standing 'reduces risk of heart attacks and cancer'
With scores of surgeries closing, what hope is there for the David Cameron's promise of 5,000 more GPs and a 24/7 NHS?

The big NHS question

Why are there so few new GPs when so many want to study medicine?
Big knickers are back: Thongs ain't what they used to be

Thongs ain't what they used to be

Big knickers are back
Thurston Moore interview

Thurston Moore interview

On living in London, Sonic Youth and musical memoirs
In full bloom

In full bloom

Floral print womenswear
From leading man to Elephant Man, Bradley Cooper is terrific

From leading man to Elephant Man

Bradley Cooper is terrific